Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
12,208 total articles
AppLovin (APP) has been punished hard — a 43.65% drawdown from peak — but the business still produces strong free cash flow, exceptional margins, and attractive ROE. This trade idea lays out a long-term (180 trading days) buy with exact entry, stop and target, and a balanced risk framework.
Tetra Technologies (TTI) sits at the intersection of two secular trends that matter to oilfield services and specialty chemicals: growing demand for engineered completion fluids and an expanding market for water management and desalination solutions. With a ~$962M market cap, positive revenue momentum, and an EV/EBITDA of 11.16, TTI looks like an a…
MakeMyTrip (MMYT) looks like a tactical long after recent weakness: the shares trade below near-term technicals and are materially oversold (RSI ~30), while corporate wins, an OpenAI tie-up and a planned local listing could re-rate the stock. Valuation is rich on headline multiples, but a successful India listing and continued margin recovery provi…
VVX has pulled back into the low $70s on heavy shorting and a momentum washout. The fundamentals - a multi-billion dollar contract backlog, positive adjusted earnings growth, and $121.5M in free cash flow - support a tactical long. We'll outline an entry at $72.09, stop at $66.00, and a target at $85.00 for a mid-term trade (45 trading days).
Salesforce's Agentforce adoption and record buyback program have materially de-risked the story. With stabilized double-digit revenue growth, free cash flow strength and a valuation that doesn't fully price sustained AI-driven monetization, we lay out a long-term trade plan: entry $258.72, target $320.00, stop $235.00, horizon 180 trading days.
On Holding (ONON) plunged after its latest quarter on a modest revenue miss and analyst downgrades, but its underlying margins, direct-to-consumer momentum, and APAC strength argue the pullback is disconnected from fundamentals. The technical set-up and heavy short activity create a tactical swing opportunity. Trade plan provided with precise entry…
Amplitude has moved back above key moving averages on accelerating volume, supported by renewed free cash flow, product momentum in AI analytics and a sizeable buyback authorization. With a $1.7B market cap and a compressed risk premium after months of weakness, we favor a tactical long into this rebound while guarding downside with a tight stop.
Dorchester Minerals (DMLP) looks like a classic royalty/mineral income story: high cash conversion, meaningful free cash flow, and a portfolio that grows through accretive acreage deals. Expect a distribution compression next quarter; that will be noisy and likely trigger knee-jerk selling. That volatility is a buying opportunity if you stick to an…
Nvidia remains the primary beneficiary of the generational AI compute cycle. Near-term headlines about an 'AI slowdown' are creating tactical buying opportunities. This trade idea outlines a disciplined long with explicit entry at $850.00, a stop at $700.00, and a target at $1100.00 over a 180-trading-day horizon.
Rubrik is benefiting from an AI-driven surge in enterprise security spending. Recent beats and a profitable quarter cooled off with post-earnings profit-taking, creating a cleaner entry for a tactical long. Valuation is rich but cash flow and growth offer room for upside; risk management is essential.
Advanced Micro Devices (AMD) has been tarred with the same brush as other AI-exposed semiconductors during a recent sector-wide selloff, but the company's fundamentals and technical read suggest a tactical long. With a market cap near $822B, strong free cash flow, low leverage, and bullish momentum indicators, AMD looks positioned to recover if AI …
Wheaton Precious Metals (WPM) is a best-in-class precious-metals streamer with durable production growth and low operating risk. That quality shows up in margins and predictable cash flows, but the stock trades at a steep premium - roughly $67.7B market cap, ~33x trailing P/E and ~7x book - leaving limited room for error. This trade idea proposes a…
Meta is trading at roughly $671 with a $1.71T market cap, strong free cash flow and accelerating AI product monetization. This trade idea lays out an actionable long with entry, stop and $1,000 target, plus catalysts and balanced risks.
Coherent (COHR) just pulled back after an earnings-fueled run. Fundamentals remain intact — revenue growth north of 30% YoY, Q1 guidance implying ~45% growth, and a multimillion-dollar hyperscaler backdrop — while technically the stock sits below short-term moving averages. This trade is a mid-term, tactical long to ride continued AI optics adoptio…
Lakefront Biotherapeutics trades below book with a market cap of roughly $1.78B while carrying a deeper pipeline and recent FDA orphan designation for gamgertamig. Technicals show near-term weakness, but the combination of shareholder accumulation and regulatory catalysts supports a mid-term long trade with tight risk controls.
Texas Instruments (TXN) looks set to extend its earnings recovery as industrial and auto demand normalize and unit pricing stabilizes for analog chips. This is a mid-term swing trade: enter on strength or a clean pullback, keep exposure limited, and ride a re-acceleration in margins and buyback-driven EPS tailwinds.
Credo (CRDO) plunged after a Q1 beat as investors punished margin moves and dilution fears. I doubled down at roughly $152.69 because the business is executing in AI data-center connectivity, growth is enormous, cash flow is positive and the balance sheet is clean. This is an aggressive, high-volatility long with a strict stop and a 180-trading-day…
T. Rowe Price (TROW) trades at roughly a 10x P/E and a ~7.4% FCF yield on a $22.6B market cap. With active ETF product momentum, a newly launched crypto ETF, a sizable dividend (quarterly $1.30), and a clean balance sheet (zero long-term debt), the stock is a tactical buy in the mid-term for income and asymmetric upside while analysts remain overwh…
Coherent's exposure to AI-driven optical demand and recent earnings strength create a buy-the-dip setup after a sharp pullback. The business prints high growth, manageable leverage and an attractive risk/reward if investors buy near current levels with a disciplined stop. Valuation is rich on multiples today, but liquidity and secular tailwinds und…
Boston Scientific (BSX) is trading near its 52-week low despite healthy cash flow, reasonable multiples, and large addressable markets in cardiology and AFib. We upgrade to a buy and lay out an actionable trade with entry, stop, and target keyed to a 180 trading-day horizon while also showing shorter horizon alternatives.
B2Gold (BTG) has cleaned up a major balance-sheet overhang and is positioned for a working-capital and cash-flow inflection as regional projects ramp. The shares are offering a defined-risk entry with upside to $6.25 if the company's operational normalisation and $325M financing tailwinds translate into tangible free cash generation.
Venture Global (GLNG) is positioned to benefit as global gas markets tighten and U.S. export volumes normalize. We lay out an actionable long trade with explicit entry, target and stop, a timeline for the position, and the key catalysts and risks that would validate or invalidate the thesis.
Butler National (BUKS) is showing accelerating aerospace-derived revenue and margins, driven by Avcon and Butler-Tempe special-mission work. Recent FAA STCs, a $37.0 million backlog, and aggressive buybacks coupled with improving profitability create a tactical long opportunity. Trade plan targets near-term upside to $6.00 with a mid-term horizon t…
Plains GP (PAGP) looks attractively priced relative to its cash generation. A transformative NGL divestiture and continued Permian throughput growth should accelerate debt paydown and re-rate the units. This trade targets capital appreciation with a defined stop to protect against regulatory or commodity setbacks.
Nebius (NBIS) has been under pressure from capex concerns and headline-driven volatility, but recent operational wins, a large customer backlog and falling short interest weaken the pure bear narrative. This trade idea offers a mid-term long with defined entry, stop and target while highlighting execution and dilution risks investors must watch.
